Geriatric study in municipality of Fatih: sarcopenia and sarcopenic obesity in elderly patients according to different indexes

Creative Commons License

Kılıç C., Bahat-Öztürk G., Tufan F., Avcı Kılıvan S., Akcan T., Medik Y., ...More

12th International Congress of the European Union Geriatric Medicine Society, Lisbon, Portugal, 5 - 07 October 2016, pp.124

  • Publication Type: Conference Paper / Summary Text
  • City: Lisbon
  • Country: Portugal
  • Page Numbers: pp.124
  • Istanbul University Affiliated: Yes


Introduction: In our study we evaluate patients with different definitions of sarcopenia and sarcopenic obesity and compare prevalence of cases.

Methods: We enrolled patients ages between 60 and 101. Skeletal muscle mass were measured with bioimpedance analyse (TANITA BC532). Muscle mass assessed with Baumgartner-index. In addition; muscle mass values calculated according to Janssen, FNIHa and FNIHb definitions and low muscle mass evaluated according to national data base. Low body mass was defined as a <9.2 kg/m2 and <7.4 kg/m2 or <32 kg and <22 kg in male and female patients respectively. Sarcopenia defined as low-skeletal-muscle-mass-index and decreasing in muscle function according to EWGSOP’s-sarcopenia definition. Our population’s data <33 cm accepted as a low-calf circumference. Together with, obesity assessed with two different definition; a percentage body fat >=60TH percentile or BMI 30 kg/m2 suggested in literature.

Results: Thiswas a study of 204 elderly patients.(mean-age:75,4 ± 7.3). Sarcopenia and its components’ prevalence are as follows: Sarcopenia (S) according to Baumgartner index: 5.3%, low muscle mass: %9.8, dynapenia: %51.5, slower walking tempo: %25.6. On the other hand; S-prevalence according to Janssen, FNIHa & FNIHb were: 29.3%,37.9% and 18%, respectively. Lower calf circumference as an indirect indicator of lower body-mass was %15,8. SO-prevalence measured with Baumgartner-BMI is 0%, with FNIHa-BMI is 24.9%, with FNIHb-BMI is 13.2%. Besides; SO-prevalence measured with Baumgartner-Zoico ile 2.1%, with Janssen-Zoico is 18.2%, with FNIHa-Zoico is %23.4, with FNIHb-Zoico is 14.7%. S-prevalence is higher among women with Janssen and FNIHa (p < 0.001). Similarly, SO-prevalence is higher among women with Janssen-BMI, FNIHa-BMI, FNIHb-BMI, Janssen-Zoico&FNIHa-Zoico (p < 0.001, p < 0.001, p = 0.02, p < 0.001, p = 0.003). According to Baumgartner-Zoico definition women don’t have SO thereby it is more common in men, meaningfully (p = 0.012).

Key conclusions: SO-prevalence have been the lowest according to Baumgartner index. The highest S-prevalence has been detected with FNIHa description and the lowest has been detected with FNIHb. S&SO correlation with gender vary among different methods. Our results have shown that S&SO is most likely higher in women.